Concepedia

Vanaja Jaligam

VJ

Statistics

Publications

5

Citations

508

H-Index

5

Active since

2007

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Medical University of South Carolina

Victoria University of Wellington

Vanaja Jaligam is an author at National Institute on Drug Abuse specializing in neuroscience, neurotransmission, and life sciences.

Publications per year

2007–2014

5

Publications

5

D2 Receptors Regulate Dopamine Transporter Function via an Extracellular Signal-Regulated Kinases 1 and 2-Dependent and Phosphoinositide 3 Kinase-Independent Mechanism

Elizabeth Bolan, Bronwyn M. Kivell, Vanaja Jaligam et al. · Molecular Pharmacology · 2007 · 205 citations

, , +17

Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors

Agustin Zapata, Bronwyn M. Kivell, Yang Han et al. · Journal of Biological Chemistry · 2007 · 125 citations · Full text

, , +17

Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism

Bronwyn M. Kivell, Željko Uzelac, Santhanalakshmi Sundaramurthy et al. · Neuropharmacology · 2014 · 105 citations · Full text

, , +14

Real‐time, spatially resolved analysis of serotonin transporter activity and regulation using the fluorescent substrate, ASP<sup>+</sup>

Murat Öz, Therissa A. Libby, Bronwyn M. Kivell et al. · Journal of Neurochemistry · 2010 · 43 citations · Full text

, , +17

The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor‐independent mechanism

Murat Öz, Vanaja Jaligam, Sehamuddin Galadari et al. · Journal of Neurochemistry · 2009 · 30 citations · Full text

, , +13

1–5 of 5